Top

Published in:

01-08-2018 | Neurological Update

Patent foramen ovale and stroke

Authors: Bruno Miranda, Ana Catarina Fonseca, José M. Ferro

Published in: Journal of Neurology | Issue 8/2018

Abstract

A patent foramen ovale (PFO) is a highly prevalent finding in cryptogenic ischaemic stroke, particularly in young adults. A common challenge in clinical practice is to distinguish between incidental and pathogenic PFO. Some clinical features and tools such as the Risk of Paradoxical Embolism score may help determining the probability of a stroke-related PFO. Nonetheless, the best therapeutic option to reduce stroke recurrence after a cryptogenic stroke with PFO has been a matter of debate for a long time. We review the mechanisms of stroke-related PFO, together with its clinical features and diagnostic criteria. In addition, we focus on the methodological details and results from new studies in the field of secondary prevention. In contrast to prior evidence, the data from three recent clinical trials and an updated meta-analysis favour PFO closure over medical treatment after cryptogenic stroke/TIA for the prevention of stroke recurrence. The PFO closure device procedure is not associated with higher mortality or cardiovascular events, except for a small increase in the occurrence of transient atrial fibrillation. Furthermore, the benefit of PFO closure was higher among those with atrial septal aneurysm and PFO with large right-to-left shunt. Future studies should address pending issues such as the option for anticoagulants or antiplatelet in patients not undergoing closure, the duration of antiplatelet treatment after PFO closure and the role of PFO closure in patients older than 60.

Alsheikh-Ali AA, Thaler DE, Kent DM (2009) Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 40:2349–2355CrossRefPubMedPubMedCentral

Kent DM, Ruthazer R, Weimar C, Mas JL, Serena J, Homma S, Di Angelantonio E, Di Tullio MR, Lutz JS, Elkind MS, Griffith J, Jaigobin C, Mattle HP, Michel P, Mono ML, Nedeltchev K, Papetti F, Thaler DE (2013) An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology 81:619–625CrossRefPubMedPubMedCentral

Wessler BS, Thaler DE, Ruthazer R, Weimar C, Di Tullio MR, Elkind MS, Homma S, Lutz JS, Mas JL, Mattle HP, Meier B, Nedeltchev K, Papetti F, Di Angelantonio E, Reisman M, Serena J, Kent DM (2014) Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale: analysis of putative high-risk features from the risk of paradoxical embolism database. Circ Cardiovasc Imaging 7:125–131CrossRefPubMed

Almekhlafi MA, Wilton SB, Rabi DM, Ghali WA, Lorenzetti DL, Hill MD (2009) Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis. Neurology 73:89–97CrossRefPubMed

Katsanos AH, Spence JD, Bogiatzi C, Parissis J, Giannopoulos S, Frogoudaki A, Safouris A, Voumvourakis K, Tsivgoulis G (2014) Recurrent stroke and patent foramen ovale: a systematic review and meta-analysis. Stroke 45:3352–3359CrossRefPubMed

Thaler DE, Ruthazer R, Weimar C, Mas JL, Serena J, Di Angelantonio E, Papetti F, Homma S, Mattle HP, Nedeltchev K, Mono ML, Jaigobin C, Michel P, Elkind MS, Di Tullio MR, Lutz JS, Griffith J, Kent DM (2014) Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology 15(83):221–226CrossRef

Hanley PC, Tajik AJ, Hynes JK, Edwards WD, Reeder GS, Hagler DJ, Seward JB (1985) Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6:1370–1382CrossRefPubMed

Horton SC, Bunch TJ (2004) Patent foramen ovale and stroke. Mayo Clin Proc 79:79–88CrossRefPubMed

Chaturvedi S (1998) Coagulation abnormalities in adults with cryptogenic stroke and patent foramen ovale. J Neurol Sci 160:158–160CrossRefPubMed

10.

Falk V, Walther T, Krankenberg H, Mohr FW (1997) Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 45:90–92CrossRefPubMed

11.

Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Heuzey JY, Amarenco P (2000) Significant association of atrial vulnerability with atrial septal abnormalities. Stroke 31:398–403CrossRefPubMed

12.

Liberman AL, Daruwalla VJ, Collins JD, Maas MB, Botelho MP, Ayache JB, Carr J, Ruff I, Bernstein RA, Alberts MJ, Prabhakaran S (2014) Diagnostic yield of pelvic magnetic resonance venography in patients with cryptogenic stroke and patent foramen ovale. Stroke 45:2324–2329CrossRefPubMed

13.

Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y, American Society of Echocardiography; Society for Cardiac Angiography and Interventions (2015) Guidelines for the echocardiographic assessment of atrial septal defect and patent foramen ovale: from the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 28:910–958CrossRefPubMed

14.

Saric M, Armour AC, Arnaout MS, Chaudhry FA, Grimm RA, Kronzon I, Landeck BF, Maganti K, Michelena HI, Tolstrup K (2016) Guidelines for the use of echocardiography in the evaluation of a cardiac source of embolism. J Am Soc Echocardiogr 29:1–42CrossRefPubMed

15.

Mojadidi MK, Roberts SC, Winoker JS, Romero J, Goodman-Meza D, Gevorgyan R, Tobis JM (2014) Accuracy of transcranial Doppler for the diagnosis of intracardiac right-to-left shunt: a bivariate meta-analysis of prospective studies. JACC Cardiovasc Imaging 7:236–250CrossRefPubMed

16.

Jauss M, Zanette E (2000) Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis 10:490–496CrossRefPubMed

17.

Lange MC, Zétola VF, deSouza AM, Novak FM, Piovesan EJ, Werneck LC (2010) Intracranial embolism characteristics in PFO patients: a comparison between positive and negative PFO by transesophageal echocardiography: the rule of nine. J Neurol Sci 293:106–109CrossRefPubMed

18.

Furlan AJ, Reisman M, Massaro J, Mauri L, Adams H, Albers GW, Felberg R, Herrmann H, Kar S, Landzberg M, Raizner A, Wechsler L, CLOSUREI Investigators (2012) Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 366:991–999CrossRefPubMed

19.

Meier B, Kalesan B, Mattle HP, Khattab AA, Hildick-Smith D, Dudek D, Andersen G, Ibrahim R, Schuler G, Walton AS, Wahl A, Windecker S, Jüni P, Trial Investigators PC (2013) Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 368:1083–1091CrossRefPubMed

20.

Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2013) Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 368:1092–1100CrossRefPubMed

21.

Ntaios G, Papavasileiou V, Makaritsis K, Michel P (2013) PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis. Int J Cardiol 169:101–105CrossRefPubMed

22.

Mas JL, Derumeaux G, Guillon B, Massardier E, Hosseini H, Mechtouff L, Arquizan C, Béjot Y, Vuillier F, Detante O, Guidoux C, Canaple S, Vaduva C, Dequatre-Ponchelle N, Sibon I, Garnier P, Ferrier A, Timsit S, Robinet-Borgomano E, Sablot D, Lacour JC, Zuber M, Favrole P, Pinel JF, Apoil M, Reiner P, Lefebvre C, Guérin P, Piot C, Rossi R, Dubois-Randé JL, Eicher JC, Meneveau N, Lusson JR, Bertrand B, Schleich JM, Godart F, Thambo JB, Leborgne L, Michel P, Pierard L, Turc G, Barthelet M, Charles-Nelson A, Weimar C, Moulin T, Juliard JM, Chatellier G, CLOSE Investigators (2017) Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke. N Engl J Med 377:1011–1021CrossRefPubMed

23.

Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, Settergren M, Sjöstrand C, Roine RO, Hildick-Smith D, Spence JD, Thomassen L, Gore REDUCE Clinical Study Investigators (2017) Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 377:1033–1042CrossRefPubMed

24.

Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, Tirschwell DL, RESPECT Investigators (2017) Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 377:1022–1032CrossRefPubMed

25.

Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Weimar C, Serena J, Meier B, Mattle HP, Di Angelantonio E, Paciaroni M, Schuchlenz H, Homma S, Lutz JS, Thaler DE (2015) Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. Eur Heart J 36:2381–2389CrossRefPubMedPubMedCentral

26.

Ntaios G, Papavasileiou V, Sagris D, Makaritsis K, Vemmos K, Steiner T, Michel P (2018) Closure of patent foramen ovale versus medical therapy in patients with cryptogenic stroke or transient ischemic attack: updated systematic review and meta-analysis. Stroke 49:412–418CrossRefPubMed

27.

Abo-Salem E, Chaitman B, Helmy T, Boakye EA, Alkhawam H, Lim M (2018) Patent foramen ovale closure versus medical therapy in cases with cryptogenic stroke, meta-analysis of randomized controlled trials. J Neurol. https://doi.org/10.1007/s00415-018-8750 PubMedCrossRef

28.

Niu X, Ou-Yang G, Yan PF, Huang SL, Zhang ZT, Zhang ZH (2018) Closure of patent foramen ovale for cryptogenic stroke patients: an updated systematic review and meta-analysis of randomized trials. J Neurol. https://doi.org/10.1007/s00415-018-8766-2 PubMedCrossRef

Title: Patent foramen ovale and stroke
Authors: Bruno Miranda
Ana Catarina Fonseca
José M. Ferro
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 8/2018
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-018-8865-0

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Patent foramen ovale and stroke

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Neuromyelitis optica: suicide risk and psychiatric comorbidities

Cutaneous somatic and autonomic nerve TDP-43 deposition in amyotrophic lateral sclerosis

Two-year real-life efficacy, tolerability and safety of dimethyl fumarate in an Italian multicentre study

Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH

Fatigue, not self-rated motor symptom severity, affects quality of life in functional motor disorders

Can epilepsy be treated by antibiotics?